Global Topical Pain Relief Market Expected to Reach $13,276 million, Globally, by 2025 with key players Johnson & Johnson, Novartis AG, GlaxoSmithKline Plc., Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi S.A., Topical BioMedics, Inc., AdvaCare Pharma,

According to a new report published by Allied Market Research, titled, Topical Pain Relief Market, by Therapeutic Class, Type, Formulation, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 20182025," the global topical pain relief market was valued at $7,481 million in 2017, and is projected to reach $13,276 million in 2025, registering a CAGR of 7.4% from 2017 to 2025.

Topical pain relief medications are pain killers that are directly applied, rubbed, or sprayed on the skin over painful muscles or joints. They are designed to relieve pain as they are composed of different ingredients such as opioids, nonsteroidal anti-inflammatory drugs (NSAIDS), salicylates, capsaicin, and others. These products have a heating or cooling effect that stimulate the nerves near the pain point and relieve pain. When pain is localized, patients highly prefer topical treatments as adjunctive therapy, which can be as effective as oral treatments and cause fewer side effects.

Get sample copy of this report at:
https://www.alliedmarketresearch.com/request-sample/4663

The pharmacies & drug stores segment is the largest segment in the global topical pain relief market, and is estimated to expand at a CAGR of 6.9% during the forecast period. On the other hand, e-commerce segment is anticipated to record highest CAGR during the forecast period.

Key Findings of the Topical Pain Relief Market :

• The opioids segment accounted for nearly one-fourth share of the global topical pain relief market in 2017.

• The over-the-counter pain relief segment is expected to grow at highest CAGR from 2018 to 2025.

• The spray segment accounted for around one-eighth share of the global market in 2017.

• Europe accounted for around one-fourth share of the global market in 2017.

• LAMEA is expected to provide lucrative market growth opportunities from 2017 to 2025.

Get customized report at:
https://www.alliedmarketresearch.com/request-for-customization/4663

North America was the leading revenue contributor to the global topical pain relief market in 2017, and is expected to dominate the market during the forecast period. This is attributed to the early approval of topical pain relief medications and high adoption of over-the-counter pain relief products in this region. However, Asia-Pacific is expected to grow at the highest CAGR of 8.6% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness towards safe pain relief products.

Key players:

• Johnson & Johnson
• Novartis AG
• GlaxoSmithKline Plc.
• Pfizer Inc.
• Reckitt Benckiser Group Plc.
• Sanofi S.A.
• Topical BioMedics Inc.
• AdvaCare Pharma
• Sun Pharmaceutical Industries Ltd.
• Nestle S.A.Troy Healthcare LLC
• Emami Group
• Chattem Inc.
• Exzell Pharma
• Performance Health Technologies Inc

Table of content:


Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. By Therapeutic Class
1.3.2. By Type
1.3.3. By Formulation
1.3.4. By Distribution Channel
1.3.5. By Region
1.3.6. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Top player positioning, 2017
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in prevalence of arthritis
3.4.1.2. Growth in geriatric population
3.4.1.3. High demand for topical pain relief products by sportsperson
3.4.1.4. Lesser side effects caused by topical pain relief products as compared to oral medicines

3.4.2. Restraints

3.4.2.1. Topical pain relief sometimes cause skin irritants
3.4.2.2. Topical pain relief are characterized by unpleasant odor

3.4.3. Opportunities

3.4.3.1. Emergence of online pharmacy
3.4.3.2. Opportunities in emerging economies

3.4.4. Impact analyses

3.5. Patent analysis (2013-2018)

3.5.1. Patent analysis, by year
3.5.2. Patent analysis for U.S., by year

Get access to the full summary at:
https://www.alliedmarketresearch.com/topical-pain-relief-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
David c
Deep joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.